Viewing Study NCT06025071



Ignite Creation Date: 2024-05-06 @ 7:29 PM
Last Modification Date: 2024-10-26 @ 3:07 PM
Study NCT ID: NCT06025071
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-09-06
First Post: 2023-06-02

Brief Title: Residual Inflammatory Risk-Guided colcHicine in Elderly Trial
Sponsor: Chinese Academy of Medical Sciences Fuwai Hospital
Organization: Chinese Academy of Medical Sciences Fuwai Hospital

Study Overview

Official Title: Efficacy and Safety of Residual Inflammatory Risk-Guided Low-dose Colchicine Therapy in Elderly Patients With Multivessel Coronary Artery Disease A Multicenter Randomized Controlled Trial
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RIGHT
Brief Summary: The goal of this clinical trial is to compare low-dose colchicine 05 mg Once Daily with no specific intervention in selected elderly patients 60-80 years old with residual inflammatory risk hs-CRP 2mgL and multivessel coronary artery disease The main questions it aims to answer are

Whether the intervention is effective in reducing ischemic events
Whether the intervention is effective in reducing inflammatory biomarkers level
Whether the intervention is safe for elderly patients

Participants will be randomized to receive low-dose colchicine 05 mg Once Daily or no specific intervention for one year Patients enrolled should complete one-year follow-up in the form of clinic visit or telephone call
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None